The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
Diabetic kidney disease (DKD) has become the major cause of chronic kidney disease or end-stage renal disease. There is still a need for innovative treatment strategies for preventing, arresting, treating, and reversing DKD, and a plethora of scientific evidence has revealed that Chinese herbal mono...
Main Authors: | Yiwei Gao, Xin Su, Taiqi Xue, Ning Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223003864 |
Similar Items
-
Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01) -
Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
by: Lei X, et al.
Published: (2018-09-01) -
Protective effect of Astragaloside IV-incubated adipose-derived stem cells on diabetic nephropathy rats based upon autophagy
by: Jun-li Gao, et al.
Published: (2024-01-01) -
Protective Effect of <i>Astragaloside IV</i> against Cadmium-Induced Damage on Mouse Renal Podocytes (MPC5)
by: Pin Gong, et al.
Published: (2023-06-01) -
Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)